Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 1Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 4vorasidenib 2Lomustine 2Blood Specimen Collection 2trametinib 1tovorafenib 1posaconazole 1perillyl alcohol 1pembrolizumab 1niraparib 1mirdametinib 1gallium maltolate 1dabrafenib 1cemiplimab 1Urination 1Transurethral Resection of Bladder 1Standard of Care 1Spinal Puncture 1Specimen Handling 1Sitagliptin Phosphate 1Receptors, Interleukin-8B 1Radiotherapy 1Radiation 1Positron Emission Tomography Computed Tomography 1Physical Therapy Modalities 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Ketoconazole 1Histocompatibility Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Glioma × posaconazole × Clear all
NCT03763396 2024-03-08

Azoles Targeting Recurrent High Grade Gliomas

University Health Network, Toronto

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡